柠檬酸镁结构式
|
常用名 | 柠檬酸镁 | 英文名 | Magnesium citrate |
|---|---|---|---|---|
| CAS号 | 144-23-0 | 分子量 | 214.413 | |
| 密度 | N/A | 沸点 | 309.6ºC at 760mmHg | |
| 分子式 | C6H6MgO7 | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 155.2ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
柠檬酸镁用途【用途一】 用于制药工业 |
| 中文名 | 柠檬酸镁 |
|---|---|
| 英文名 | magnesium citrate |
| 英文别名 | 更多 |
| 沸点 | 309.6ºC at 760mmHg |
|---|---|
| 分子式 | C6H6MgO7 |
| 分子量 | 214.413 |
| 闪点 | 155.2ºC |
| 精确质量 | 213.996399 |
| PSA | 110.13000 |
| InChIKey | DIXGJWCZQHXZNR-UHFFFAOYSA-L |
| SMILES | O=C([O-])CC(O)(CC(=O)[O-])C(=O)O.[Mg+2] |
| 外观性状 | 白色粉末 |
| 储存条件 | 密封于干燥阴凉处保存。 |
| 稳定性 | 常温常压下稳定。 |
| 计算化学 | 四、计算化学数据: 1、 氢键供体数量:2 2、 氢键受体数量:7 3、 可旋转化学键数量:3 4、 拓扑分子极性表面积(TPSA):138 5、 重原子数量:14 6、 表面电荷:0 7、 复杂度:216 8、 同位素原子数量:0 9、 确定原子立构中心数量:0 10、 不确定原子立构中心数量:0 11、 确定化学键立构中心数量:0 12、 不确定化学键立构中心数量:0 13、 共价键单元数量:2 |
| 更多 | 一、物性数据 1. 性状:白色或黄色粉末 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| 危害码 (欧洲) | Xi |
| 风险声明 (欧洲) | 36/37/38 |
| 安全声明 (欧洲) | S23-S24/25 |
| 危险品运输编码 | NONH for all modes of transport |
| WGK德国 | 2 |
| RTECS号 | SA4250000 |
| 海关编码 | 2918150000 |
| 海关编码 | 2918150000 |
|---|---|
| 中文概述 | 2918150000. 柠檬酸盐和柠檬酸酯. 增值税率:17.0%. 退税率:13.0%. 监管条件:4ABxy(出口许可证,入境货物通关单,出境货物通关单出口许可证(加工贸易),出口许可证(边境小额贸易)). 最惠国关税:6.5%. 普通关税:30.0% |
| 申报要素 | 品名, 成分含量, 用途 |
| 监管条件 | 4.出口许可证 A.入境货物通关单 B.出境货物通关单 x.出口许可证(加工贸易) y.出口许可证(边境小额贸易) |
| 检验检疫 | R.进口食品卫生监督检验 S.出口食品卫生监督检验 N.出口商品检验 |
| Summary | 2918150000. other salts and esters of citric acid. VAT:17.0%. Tax rebate rate:13.0%. Supervision conditions:4ABXY(export license,certificate of inspection for goods inward,certificate of inspection for goods outwardexport license(processing trade),export license(border small volume trade)). MFN tariff:6.5%. General tariff:30.0% |
|
Solid state compatibility study and characterization of a novel degradation product of tacrolimus in formulation.
J. Pharm. Biomed. Anal. 110 , 67-75, (2015) Tacrolimus is macrolide drug that is widely used as a potent immunosuppressant. In the present work compatibility testing was conducted on physical mixtures of tacrolimus with excipients and on compat... |
|
|
A green heterogeneous synthesis of N-doped carbon dots and their photoluminescence applications in solid and aqueous states.
Nanoscale 6(17) , 10307-15, (2014) Compared with traditional semiconductor quantum dots (QDs) and organic dyes, photoluminescent carbon dots (CDs) are superior because of their high aqueous solubility, robust chemical inertness, facile... |
|
|
Computed tomography colonography technique: the role of intracolonic gas volume.
Radiol Res Pract 2013 , 517246, (2014) Introduction. Poor distention decreases the sensitivity and specificity of CTC. The total volume of gas administered will vary according to many factors. We aim to determine the relationship between t... |
| 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt (1:1) |
| Magnesium citrate |
| CitricAcid,MagnesiumSalt,Dibasic |
| Magnesium citrate dibasic,anhydrous |
| 1,2,3-Propanetricarboxylic acid, 2-hydroxy-, magnesium salt |
| 3-Carboxy-3-hydroxypentanedioate de magnésium |
| Magnesium-3-carboxy-3-hydroxypentandioat |
| Magnesium hydrogen citrate |
| Magnesium citrate tetradecahydrate |
| MFCD00151706 |
| magnesiumhydrogencitrate |
| Magnesium 3-carboxy-3-hydroxypentanedioate |
| magnesium 3-carboxy-3-hydroxy-glutarate |
| MAGNESIUMCITRATE |
| EINECS 231-923-9 |
| MagnesiuM Citrate 5H2O |